@article {Morita19004770, author = {Mizuki Morita and Soichi Ogishima}, title = {Challenges in Building and Maintaining Rare Disease Patient Registries: Results of a Questionnaire Survey in Japan at 2012}, elocation-id = {19004770}, year = {2019}, doi = {10.1101/19004770}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Background Research infrastructure such as patient registries and biobanks is expected to play important roles by aggregating information and biospecimens to promote research and development for rare diseases. However, both building and maintaining them can be costly. This paper presents results of a survey of patient registries for rare diseases in Japan conducted at the end of 2012, with emphasis on clarifying costs and efforts related to building and maintaining them.Results Of 31 patient registries in Japan found by searching a database of research grant reports and by searching the internet, 11 returned valid responses to this survey. Results show that labor and IT system costs are major expenses for developing and maintaining patient registries. Half of the respondent patient registries had no prospect of securing a budget to maintain them. Responders required the following support for patient registries: financial support, motivation of registrants (medical doctors or patients), and improved communication with and visibility to potential data users. These results resemble those reported from another survey conducted almost simultaneously in Europe (EPIRARE survey).Conclusions Survey results imply that costs and efforts to build and maintain patient registries for many rare diseases make them unrealistic. Some alternative strategy is necessary to reduce burdens, such as offering a platform that supplies IT infrastructure and basic secretariat functions that can be used commonly among many patient registries.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported in part by a Health Labour Sciences Research Grant from the Ministry of Health Labour and Welfare (MHLW).Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.Not ApplicableAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Not ApplicablenaBTMUBank of Tokyo-Mitsubishi UFJCINClinical Innovation NetworkEPIRAREEuropean Platform for Rare Diseases RegistriesEUCERDEuropean Union Committee of Experts on Rare DiseasesEUREuroGBPPound SterlingITInformation TechnologyJPYJapanese YenMHLWMinistry of Health, Labour and WelfareMURCMitsubishi UFJ Research and ConsultingNCsNational CentersRDTFRare Diseases Task ForceTTBTelegraphic Transfer Buying rateTTSTelegraphic Transfer Selling rateUSDUS Dollar}, URL = {https://www.medrxiv.org/content/early/2019/08/17/19004770}, eprint = {https://www.medrxiv.org/content/early/2019/08/17/19004770.full.pdf}, journal = {medRxiv} }